ROLE OF AMALAKI IN DIABETES MELLITUS – A REVIEW
Abstract
Diabetes is an “iceberg” disease. The prevalence of Diabetes is rapidly rising all over the globe at an alarming rate. Diabetes Mellitus occurs throughout the world, but it is more common; especially Type-2 Diabetes Mellitus in the developed countries. WHO predicted that 30 million people were diagnosed with Diabetes worldwide in 1985, by 1995 the number had risen to 135 million and at the current rate there will be some 592 million by the year 2035.In India, it is estimated that by year 2045 it is rise to 134.3 million (IDF).
In Ayurvedic classics almost all the Acharyashas quoted Amalakias a Rasayanaand highlighted it’s Pramehaghna property too. Our ancient Acharyas have described Amalaki as a antidiabetic drug on the basis of its Rasa, Guna, Veerya, Vipakaand Karma.Results of clinical trials, epidemiological investigations, experimental studies proved the antioxidant, hypolipidemic, immunomodulatory and hypoglycemic propertyof Amalaki.. So Amalaki can be used as an adjuant therapy for DM.
Key Word: Type 2 Diabetes, Madhumeha, AmalakiChurna
References
Huizinga MM, Rothman RL. Addressing the diabetes pandemic: A comprehensive approach. Indian J Med Res. 2006; 124: 481-484.
Nita Gandhi, et.al. Epidemiology of Diabetes Medicine (Abingdon). Dec.2014; 42(12): 698–702.
Database on Medicinal Plants Used in Ayurveda, Published by The central council of Research in Ayurveda & Siddha, New Delhi, Year of publication. 2001; volume 3: page no.11-14.
Rao, T.P., N. Sakaguchi, L.R. Juneja, E. Wada and T. Yokozawa. Amla (EmblicaofficinalisGaertn.) extracts reduce oxidative stress in streptozotocininduced diabetic rats. J. Med. Food. 2005; 8: 362-368.
Kim, H.J.T. Yokozawa, H.Y. Kim, C. Tohda, T.P. Rao and L.R. Juneja. Influence of amla (EmblicaofficinalisGaertn.) on hypercholesterolemia and lipid peroxidation in cholesterol-fed rats. J. Nutr. Sci. Vitaminol Tokyo. 2005; 51: 413-418.
Thakur, C.P., B. Thakur, S. Singh, P.K. Sinha and S.K. Sinha. The Ayurvedic medicines Haritaki, Amala and Bahira reduce cholesterol induced atherosclerosis in rabbits. Int. J. Cardiol. 1988; 21: 167-175.
Mathur, R., A. Sharma, V.P. Dixit and M. Varma. Hypolipidaemic effect of fruit juice of Emblicaofficinalisin cholesterol-fed rabbits. J. Ethnopharmacol. 1996; 50: 61-68.
Mishra, M., U.N. Pathak and A.B. Khan. EmblicaofficinalisGaertn and serum cholesterol level in experimental rabbits. Br. J. Exp. Pathol.1981; 62: 526-528.
Sabu, M.C. and R. Kuttan. Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J. Ethanopharmacol.2002; 81: 155-160.
Tripathi, S.N., C.M. Tiwari, B.N. Upadyay and R.S. Singh. Screening of hypoglycemic action in certain indigenous drugs. Screening of hypoglycemic action in certain indigenous drugs. 1979; 14: 159-169.
Hakim, Z.S., R.A. Bangaru, D.D. Santani and R.K. Goyal. Potential antidiabetic agents from plant sources. Indian J. Nat. Prod. 1996; 11: 3-10.
Santhi Sri K.V. et al. Effect of Amla, an approach towards the control of Diabetes Mellitus. International Journal of Current Microbiology and Applied Sciences (2003); 2(9):103-108
Ibid 12
Ibid 12
Ibid 12
K.Walia, et.al. Role of Amla in Type-2 Diabetes Mellitus-A Review. Research Journal of Recent Sciences (2015); Vol.4:31-35
